Lind Global Fund II LP 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 8:12 pm Sale |
2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ |
Lind Global Fund II LP | 796 0.100% |
-1,098 (-57.95%) |
Filing |
| 2023-12-07 4:30 pm Purchase |
2023-12-04 | 13G | TransCode Therapeutics, Inc. RNAZ |
Lind Global Fund II LP | 1,894 9.900% |
1,894 (New Position) |
Filing |